Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IBRX

ImmunityBio Inc

May 05 • 04:00PM ET

7.58

+0.15 2.02 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: MRNA BNTX NVAX PFE VRTX REGN GILD ALNY AMGN BIIB

| Held by: VTI XBI VB IWM VBK VXF IBB IWO VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.39	Insider Own	64.09%	Shs Outstand	1.01B	Perf Week	8.91%
Market Cap	7.79B	Forward P/E	-	EPS next Y	-0.06	Insider Trans	-0.08%	Shs Float	369.20M	Perf Month	7.06%
Enterprise Value	8.40B	PEG	-	EPS next Q	-0.07	Inst Own	16.93%	Short Float	38.01%	Perf Quarter	19.75%
Income	-351.40M	P/S	68.79	EPS this Y	32.08%	Inst Trans	6.08%	Short Ratio	5.39	Perf Half Y	215.83%
Sales	113.29M	P/B	-	EPS next Y	77.75%	ROA	-79.43%	Short Interest	140.33M	Perf YTD	282.83%
Book/sh	-0.49	P/C	32.09	EPS next 5Y	-	ROE	-	52W High	12.43 -39.02%	Perf Year	260.95%
Cash/sh	0.24	P/FCF	-	EPS past 3/5Y	28.42% 15.60%	ROIC	-104.92%	52W Low	1.83 314.21%	Perf 3Y	36.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	678.62% 299.74%	Gross Margin	85.63%	Volatility	4.90% 6.85%	Perf 5Y	-51.87%
Dividend TTM	-	EV/Sales	74.11	EPS Y/Y TTM	34.94%	Oper. Margin	-226.00%	ATR (14)	0.58	Perf 10Y	0.40%
Dividend Ex-Date	-	Quick Ratio	5.08	Sales Y/Y TTM	668.31%	Profit Margin	-310.18%	RSI (14)	50.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.10	EPS Q/Q	32.90%	SMA20	1.20%	Beta	0.07	Target Price	14.80
Payout	-	Debt/Eq	-	Sales Q/Q	406.95%	SMA50	-5.92%	Rel Volume	0.35	Prev Close	7.43
Employees	691	LT Debt/Eq	-	Earnings	Feb 23 BMO	SMA200	74.30%	Avg Volume	26.04M	Price	7.58
IPO	Jul 28, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.57% -0.20%	Trades		Volume	9,049,737	Change	2.02%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)